Australia Stock Exchange release from PARADIGM BIOPHAR : PAR REPORTS POSTIVE TOPLINE RESULTS IN HEART FAILURE MODEL
16/12/2021 24:00
Australia Stock Exchange release from PARADIGM BIOPHAR PAR.AX : PAR REPORTS POSTIVE TOPLINE RESULTS IN HEART FAILURE MODEL
Recent news on Paradigm Biopharmaceuticals
See all newsBrief: Paradigm Biopharmaceuticals Says Board Initiates Voluntary Administration
Brief: Paradigm Biopharmaceuticals Seeks Trading Halt
Australia's Paradigm Biopharmaceuticals slips on discounted placement
Brief: Paradigm Biopharmaceuticals Says Co Completes A$14 Mln Placement
Brief: Paradigm Biopharmaceuticals Requests Trading Halt